Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism

Rein B, Ma K, Yan Z. A standardized social preference protocol for measuring social deficits in mouse models of autism. Nat Protoc. 2020;15(10):3464–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nadeem A, et al. Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism. Brain Behav Immunity. 2017;61:146–54.

Article  CAS  Google Scholar 

Ebrahimi Meimand S, Rostam-Abadi Y, Rezaei N. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment. Expert Rev Clin Immunol. 2021;17(1):27–35.

Article  CAS  PubMed  Google Scholar 

Sabra A, Aderbal Filho S, Selma S. Autism: etiology, epidemiology, pathology, clinical aspects and treatment. Autism Open Access. 2020;10(3):253.

Google Scholar 

Bergeron JD, et al. White matter injury and autistic-like behavior predominantly affecting male rat offspring exposed to group B streptococcal maternal inflammation. Dev Neurosci. 2013;35(6):504–15.

Article  CAS  PubMed  Google Scholar 

Hsiao EY, et al. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci USA. 2012;109(31):12776–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lucas K, Maes M. Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol. 2013;48(1):190–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bueno BG, et al. Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci Biobehav Rev. 2016;64:134–47.

Article  Google Scholar 

Vallabhapurapu S, Karin M. Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.

Article  CAS  PubMed  Google Scholar 

Hsieh HL, Yang CM. Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int. 2013;2013(1): 484613.

PubMed  PubMed Central  Google Scholar 

Yang CM, et al. Multiple factors from bradykinin-challenged astrocytes contribute to the neuronal apoptosis: involvement of astroglial ROS, MMP-9, and HO-1/CO system. Mol Neurobiol. 2013;47(3):1020–33.

Article  CAS  PubMed  Google Scholar 

Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277(1):76–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heckmann BL, Tummers B, Green DR. Crashing the computer apoptosis vs. necroptosis in neuroinflammation. Cell Death Differ. 2019;26(1):41–52.

Article  PubMed  Google Scholar 

Emberti Gialloreti L, Curatolo P. Autism spectrum disorder: why do we know so little? Front Neurol. 2018;9:394207.

Article  Google Scholar 

Mano-Sousa BJ, et al. Effects of risperidone in autistic children and young adults: a systematic review and meta-analysis. Curr Neuropharmacol. 2021;19(4):538–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchezan J, et al. Immunological dysfunction in autism spectrum disorder: a potential target for therapy. NeuroImmunoModulation. 2019;25(5–6):300–19.

Google Scholar 

Sharma SR, Gonda X, Tarazi FI. Autism spectrum disorder: classification, diagnosis and therapy. Pharmacol Ther. 2018;190:91–104.

Article  CAS  PubMed  Google Scholar 

Kandezi N, et al. Novel insight to neuroprotective potential of curcumin: a mechanistic review of possible involvement of mitochondrial biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF signaling pathways. Int J Mol Cell Med. 2020;9(1):1–32.

CAS  PubMed  PubMed Central  Google Scholar 

Pella D, Rybar R, Mechirova V. Pleiotropic effects of statins. Acta Cardiol Sin. 2005;21(4):190.

Google Scholar 

Katsargyris A, et al. Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins. Vascular. 2011;19(6):320–6.

Article  PubMed  Google Scholar 

Pan HC, et al. Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury. Neurosurgery. 2010;67(2):376–88 (discussion 388–9).

Article  PubMed  Google Scholar 

Chen JH, et al. An early neuroprotective effect of atorvastatin against subarachnoid hemorrhage. Neural Regen Res. 2020;15(10):1947–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kho AR, et al. The effects of atorvastatin on global cerebral ischemia-induced neuronal death. Int J Mol Sci. 2021;22(9):4385.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu L, et al. Atorvastatin inhibits neuronal apoptosis via activating cAMP/PKA/p-CREB/BDNF pathway in hypoxic-ischemic neonatal rats. FASEB J. 2022;36(4): e22263.

Article  CAS  PubMed  Google Scholar 

Yang SS, et al. Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells. Cell Immunol. 2012;279(1):96–102.

Article  CAS  PubMed  Google Scholar 

Denucci BL, et al. Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder. Reprod Toxicol. 2021;106:82–93.

Article  Google Scholar 

Xu X, et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J Neuroinflammation. 2017;14(1):167.

Article  PubMed  PubMed Central  Google Scholar 

Mabunga DF, et al. Exploring the validity of valproic acid animal model of autism. Exp Neurobiol. 2015;24(4):285–300.

Article  PubMed  PubMed Central  Google Scholar 

Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018;299(Pt A):217–27.

Article  CAS  PubMed  Google Scholar 

Chaliha D, et al. A systematic review of the valproic-acid-induced rodent model of autism. Dev Neurosci. 2020;42(1):12–48.

Article  CAS  PubMed  Google Scholar 

Atia AA, et al. The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, potential role for enhanced autophagy. Psychopharmacology. 2023;240(6):1313–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism—a current review of clinical and animal studies. Neurotoxicol Teratol. 2013;36:47–56.

Article  CAS  PubMed  Google Scholar 

Mirza R, Sharma B. Benefits of fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. Brain Res Bull. 2019;147:36–46.

Article  CAS  PubMed  Google Scholar 

Markram K, et al. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology. 2008;33(4):901–12.

Article  PubMed 

Comments (0)

No login
gif